scientific-skills/Others/clinic-sample-size/SKILL.md
Unified tool for calculating sample sizes for Diagnostic, Efficacy, Etiology, and Prognosis clinical studies. Supports various statistical methods (Sensitivity/Specificity, Log-rank, Chi-square, EPV, etc.).
npx skillsauth add aipoch/medical-research-skills clinic-sample-sizeInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Python: 3.10+. Repository baseline for current packaged skills.Third-party packages: not explicitly version-pinned in this skill package. Add pinned versions if this skill needs stricter environment control.See ## Usage above for related details.
cd "20260316/scientific-skills/Others/clinic-sample-size"
python -m py_compile scripts/main.py
python scripts/main.py --help
Example run plan:
CONFIG block or documented parameters if the script uses fixed settings.python scripts/main.py with the validated inputs.scripts/calculators.py with additional helper scripts under scripts/.Run this minimal command first to verify the supported execution path:
python scripts/validate_skill.py --help
This skill integrates sample size calculations for four major types of clinical research: Diagnostic, Efficacy, Etiology, and Prognosis.
The calculation results are saved as Markdown files in the output/ directory by default. The file path is returned in the JSON output.
You can specify a custom output directory using --output_dir.
The skill is executed via the scripts/main.py script. The first argument specifies the study type: diagnostic, efficacy, etiology, or prognosis.
You can add study information to the report using:
--study_name <name>: Name of the study.--outcome <name>: Primary outcome measure.Calculates sample size for sensitivity/specificity, AUC, Kappa, or multivariable models.
Example: Sensitivity/Specificity (Full Params)
python scripts/main.py --study_name "New Biomarker Study" --outcome "Sensitivity > 0.8" diagnostic sens_spec --se 0.8 --sp 0.9 --error 0.05 --prev 0.3 --dropout 0.1
Example: Sensitivity/Specificity (Smart Inference)
# Only providing study name/outcome, tool infers se=0.85, sp=0.90, prev=0.5, etc.
python scripts/main.py --study_name "Screening Test" --outcome "Diagnosis" diagnostic sens_spec
Calculates sample size for randomized controlled trials (RCTs) or single-arm studies. Input: JSON string or file.
Example: Two-arm General (Smart Inference)
# Infers MeanT=0.5, MeanC=0 (Medium effect size), St=1, Sc=1
python scripts/main.py --study_name "Drug Trial" --outcome "Pain Score" efficacy --input '{"study_type": "general", "design": "two"}'
Calculates sample size for cohort/case-control studies.
Example: Categorical (Smart Inference)
# Infers Pt=0.2, Pc=0.1 (RR=2.0)
python scripts/main.py --study_name "Risk Factor Study" etiology --mode categorical
Calculates sample size for prediction models or prognostic factors.
Example: Prediction Model (EPV)
# Infers P=0.1 (Event rate), training_rate=0.7
python scripts/main.py prognosis epv --variables_number 10
clinic_sample_size_result.md unless the skill documentation defines a better convention.Run this minimal verification path before full execution when possible:
python scripts/calculators.py --help
Expected output format:
Result file: clinic_sample_size_result.md
Validation summary: PASS/FAIL with brief notes
Assumptions: explicit list if any
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.